# SpectraCure

Source: https://onco.cc/companies/spectracure/  
OnCo record `spectracure` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

SpectraCure is a Sweden-based medical device company running 2 late-stage cancer trials in prostate cancer.

## Summary

SpectraCure, based in Lund, Sweden, is a medical device company. SpectraCure is a medical technology company developing a photodynamic therapy (PDT) treatment system for localised prostate cancer, with potential future applications in breast, pancreatic and head/neck cancer. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in prostate cancer. The largest, NCT03067051 (Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System), plans to enrol 66 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: SpectraCure AB
- Tags: ctgov-sponsor
- HQ: Lund
- Type: devices
- Website: https://www.spectracure.com/

## Sources

- Official website: https://www.spectracure.com/
- ClinicalTrials.gov: trials led by SpectraCure: https://clinicaltrials.gov/search?lead=SpectraCure%20AB

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Devices & Physical Therapies](https://onco.cc/fronts/devices/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)
- trials: [Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System](https://onco.cc/trials/nct03067051/), [Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System](https://onco.cc/trials/nct06807359/)

---
JSON: https://onco.cc/api/v1/entities/spectracure.json